相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immune responses to human cancer stem-like cells/cancer-initiating cells
Yoshihiko Hirohashi et al.
CANCER SCIENCE (2016)
New toxicity profile for novel immunotherapy agents: focus on immune-checkpoint inhibitors
C. Ciccarese et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)
MAPK13 is preferentially expressed in gynecological cancer stem cells and has a role in the tumor-initiation
Kazuyo Yasuda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Olfactory Receptor Family 7 Subfamily C Member 1 Is a Novel Marker of Colon Cancer-Initiating Cells and Is a Potent Target of Immunotherapy
Rena Morita et al.
CLINICAL CANCER RESEARCH (2016)
Making Better Chimeric Antigen Receptors for Adoptive T-cell Therapy
Marcela V. Maus et al.
CLINICAL CANCER RESEARCH (2016)
The future of immunotherapy for sarcoma
Tomohide Tsukahara et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2016)
Prospects for gene-engineered T cell immunotherapy for solid cancers
Christopher A. Klebanoff et al.
NATURE MEDICINE (2016)
Identification of a novel human memory T-cell population with the characteristics of stem-like chemo-resistance
Kenji Murata et al.
ONCOIMMUNOLOGY (2016)
Phase II study of ipilimumab monotherapy in Japanese patients with advanced melanoma
N. Yamazaki et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
IL15 and T-cell Stemness in T-cell-Based Cancer Immunotherapy
Karolina Pilipow et al.
CANCER RESEARCH (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
Current Perspectives in Immunotherapy for Non-Small Cell Lung Cancer
Edward B. Garon
SEMINARS IN ONCOLOGY (2015)
A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1-Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response
Paul F. Robbins et al.
CLINICAL CANCER RESEARCH (2015)
Targeting PD-1/PD-L1 in the treatment of metastatic renal cell carcinoma
Matthew Weinstock et al.
THERAPEUTIC ADVANCES IN UROLOGY (2015)
Secondary Malignant Neoplasms Among Children, Adolescents, and Young Adults With Osteosarcoma
Jean S. Lee et al.
CANCER (2014)
Finding suitable targets is the major obstacle to cancer gene therapy
Steven A. Rosenberg
CANCER GENE THERAPY (2014)
Heat shock protein DNAJB8 is a novel target for immunotherapy of colon cancer-initiating cells
Rena Morita et al.
CANCER SCIENCE (2014)
Specific Targeting of a Naturally Presented Osteosarcoma Antigen, Papillomavirus Binding Factor Peptide, Using an Artificial Monoclonal Antibody
Tomohide Tsukahara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Fibroblasts induce expression of FGF4 in ovarian cancer stem-like cells/cancer-initiating cells and upregulate their tumor initiation capacity
Kazuyo Yasuda et al.
LABORATORY INVESTIGATION (2014)
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Alexandra Snyder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Cancer Immunotherapy Based on Mutation-Specific CD4+T Cells in a Patient with Epithelial Cancer
Eric Tran et al.
SCIENCE (2014)
Identification of Novel Human Leukocyte Antigen-A*0201-Restricted, Cytotoxic T Lymphocyte Epitopes on CD133 for Cancer Stem Cell Immunotherapy
Jianfei Ji et al.
STEM CELLS TRANSLATIONAL MEDICINE (2014)
Small proline-rich protein-1B is overexpressed in human oral squamous cell cancer stem-like cells and is related to their growth through activation of MAP kinase signal
Yoshitaka Michifuri et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Immunotherapeutic benefit of α-interferon (IFNα) in survivin2B-derived peptide vaccination for advanced pancreatic cancer patients
Hidekazu Kameshima et al.
CANCER SCIENCE (2013)
Prostate cancer stem-like cells/cancer-initiating cells have an autocrine system of hepatocyte growth factor
Sachiyo Nishida et al.
CANCER SCIENCE (2013)
Cancer stem cell antigen-based vaccines: the preferred strategy for active specific immunotherapy of metastatic melanoma?
Robert O. Dillman et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy
Richard A. Morgan et al.
JOURNAL OF IMMUNOTHERAPY (2013)
Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
Paul F. Robbins et al.
NATURE MEDICINE (2013)
Ectopically Expressed Variant Form of Sperm Mitochondria-Associated Cysteine-Rich Protein Augments Tumorigenicity of the Stem Cell Population of Lung Adenocarcinoma Cells
Akari Takahashi et al.
PLOS ONE (2013)
High Expression of CD109 Antigen Regulates the Phenotype of Cancer Stem-Like Cells/Cancer-Initiating Cells in the Novel Epithelioid Sarcoma Cell Line ESX and Is Related to Poor Prognosis of Soft Tissue Sarcoma
Makoto Emori et al.
PLOS ONE (2013)
HSP DNAJB8 Controls Tumor-Initiating Ability in Renal Cancer Stem-like Cells
Satoshi Nishizawa et al.
CANCER RESEARCH (2012)
SYT-SSX breakpoint peptide vaccines in patients with synovial sarcoma: A study from the Japanese Musculoskeletal Oncology Group
Satoshi Kawaguchi et al.
CANCER SCIENCE (2012)
Gene Expression Profiles of Prostate Cancer Stem Cells Isolated by Aldehyde Dehydrogenase Activity Assay
Sachiyo Nishida et al.
JOURNAL OF UROLOGY (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Targeted Therapy in Bone and Soft Tissue Sarcoma in Children and Adolescents
Patrick A. Thompson et al.
CURRENT ONCOLOGY REPORTS (2012)
Paths to stemness: building the ultimate antitumour T cell
Luca Gattinoni et al.
NATURE REVIEWS CANCER (2012)
Phase I clinical trial of survivin-derived peptide vaccine therapy for patients with advanced or recurrent oral cancer
Akihiro Miyazaki et al.
CANCER SCIENCE (2011)
Immunogenic enhancement and clinical effect by type-I interferon of anti-apoptotic protein, survivin-derived peptide vaccine, in advanced colorectal cancer patients
Hidekazu Kameshima et al.
CANCER SCIENCE (2011)
Autologous CTL response against cancer stem-like cells/cancer-initiating cells of bone malignant fibrous histiocytoma
Masanobu Kano et al.
CANCER SCIENCE (2011)
Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
Paul F. Robbins et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity
Munehide Nakatsugawa et al.
LABORATORY INVESTIGATION (2011)
A human memory T cell subset with stem cell-like properties
Luca Gattinoni et al.
NATURE MEDICINE (2011)
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
Richard A. Morgan et al.
MOLECULAR THERAPY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Side population cells have the characteristics of cancer stem-like cells/cancer-initiating cells in bone sarcomas
M. Murase et al.
BRITISH JOURNAL OF CANCER (2009)
Phase I clinical study of anti-apoptosis protein survivin-derived peptide vaccination for patients with advanced or recurrent urothelial cancer
Ichiya Honma et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
HLA-A*0201-restricted CTL epitope of a novel osteosarcoma antigen, papillomavirus binding factor
Tomohide Tsukahara et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
Prognostic impact and immunogenicity of a novel osteosarcoma antigen, papillomavirus binding factor, in patients with osteosarcoma
Tomohide Tsukahara et al.
CANCER SCIENCE (2008)
Adoptive cell transfer: a clinical path to effective cancer immunotherapy
Steven A. Rosenberg et al.
NATURE REVIEWS CANCER (2008)
Cancer regression in patients after transfer of genetically engineered lymphocytes
Richard A. Morgan et al.
SCIENCE (2006)
Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcoma
S Kawaguchi et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2005)
Identification of human autologous cytotoxic T-lymphocyte-defined osteosarcoma gene that encodes a transcriptional regulator, papillomavirus binding factor
T Tsukahara et al.
CANCER RESEARCH (2004)
Crisscross CTL induction by SYT-SSX junction peptide and its HLA-A*2402 anchor substitute
K Ida et al.
JOURNAL OF IMMUNOLOGY (2004)
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes
ME Dudley et al.
SCIENCE (2002)
Tumor-specific shared antigenic peptides recognized by human T cells
P van der Bruggen et al.
IMMUNOLOGICAL REVIEWS (2002)
Detection and induction of CTLs specific for SYT-SSX-derived peptides in HLA-A24+ patients with synovial sarcoma
Y Sato et al.
JOURNAL OF IMMUNOLOGY (2002)
分享论文
